Umoja Biopharma
Biotechnology
Develops approaches that generate cancer-fighting immune cells inside a patient’s body.
Source- Reported stage
- Series C
- Local presence
- Seattle
$100M Series C announced January 14, 2025.
Research snapshot: 2026-11-01. Funding may have changed since the linked report.